Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...
IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...
Antifibrotic treatments have similar effects in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.
Antifibrotic therapy shows similar efficacy in familial and sporadic IPF, with no significant differences in survival or acute exacerbations. Because familial idiopathic pulmonary fibrosis is ...
Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...
The MarketWatch News Department was not involved in the creation of this content. Ingelheim, Germany/Ridgefield, Connecticut, U.S. -- Idiopathic pulmonary fibrosis (IPF) is a progressive disease, ...
Research conducted in collaboration with IPF experts and the Pulmonary Fibrosis Foundation reveals critical gaps in diagnosis, treatment, and quality of life for people living with IPF Findings ...
Learn to manage chronic fatigue from IPF with exercise, nutrition, sleep hygiene, and energy-saving strategies.